Business Description
Satellos Bioscience Inc
NAICS : 541713
SIC : 3741
ISIN : CA80401L3083
Description
Financial Strength
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | 0.88 | |||||
Piotroski F-Score | 3/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | -57 | |||||
3-Year EPS without NRI Growth Rate | -50 | |||||
3-Year FCF Growth Rate | -48.8 |
Momentum Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 89.34 | |||||
9-Day RSI | 77.74 | |||||
14-Day RSI | 69.79 | |||||
6-1 Month Momentum % | 2 | |||||
12-1 Month Momentum % | 21.43 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 7.25 | |||||
Quick Ratio | 7.25 | |||||
Cash Ratio | 6.88 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -50.8 |
Profitability Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | -57.67 | |||||
ROA % | -53 | |||||
ROIC % | -639.8 | |||||
ROC (Joel Greenblatt) % | -126362.64 | |||||
ROCE % | -56.99 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PB Ratio | 2.29 | |||||
Price-to-Tangible-Book | 2.68 | |||||
EV-to-EBIT | -0.86 | |||||
EV-to-EBITDA | -0.86 | |||||
EV-to-FCF | -0.49 | |||||
Price-to-Net-Current-Asset-Value | 2.68 | |||||
Price-to-Net-Cash | 2.81 | |||||
Earnings Yield (Greenblatt) % | -116.4 | |||||
FCF Yield % | -33.39 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Satellos Bioscience Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil C$) | |||
EPS (TTM) (C$) | -0.2 | ||
Beta | 0.99 | ||
Volatility % | 79.57 | ||
14-Day RSI | 69.79 | ||
14-Day ATR (C$) | 0.031198 | ||
20-Day SMA (C$) | 0.49975 | ||
12-1 Month Momentum % | 21.43 | ||
52-Week Range (C$) | 0.29 - 0.8 | ||
Shares Outstanding (Mil) | 112.85 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Satellos Bioscience Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Satellos Bioscience Inc Stock Events
Event | Date | Price(C$) | ||
---|---|---|---|---|
No Event Data |
Satellos Bioscience Inc Frequently Asked Questions
What is Satellos Bioscience Inc(TSX:MSCL)'s stock price today?
When is next earnings date of Satellos Bioscience Inc(TSX:MSCL)?
Does Satellos Bioscience Inc(TSX:MSCL) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |